Novo Nordisk Announces Partnership with OpenAI [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk A/S (NYSE:NVO) is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk A/S (NYSE:NVO) announced on April 14 that it was partnering with OpenAI to deploy artificial intelligence across its business. The strategic partnership will allow the Wegovy-maker to better use AI to analyze complex datasets, identify promising new drugs, and reduce the time it takes for a medicine to move from the research stage to patient use. Sam Altman's OpenAI will assist Novo Nordisk A/S (NYSE:NVO) in training its global workforce, enhancing AI literacy, and boosting productivity across departments. The drugmaker revealed that pilot programmes would begin across ?research ?and development, manufacturing, and commercial operations, with full integration planned by the end of this year. Novo Nordisk A/S (NYSE:NVO) also clarified that the initiative was not intended to ?cut its current workforce, but to lift the productivity of its employees and cur
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease [Yahoo! Finance]Yahoo! Finance
- Hims & Hers (HIMS) Jumps 48% Ahead of Earnings [Yahoo! Finance]Yahoo! Finance
- Notable healthcare headlines for the week: J&J, Abbott and Organon in focus [Seeking Alpha]Seeking Alpha
- New Anthropic Board Member Signals Healthcare Push [Yahoo! Finance]Yahoo! Finance
- Novo GLP-1 drug shows less lean mass loss than rivals, study says [USA TODAY]USA TODAY
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/20/26 - Form 6-K
- 4/13/26 - Form 6-K
- 4/7/26 - Form 6-K
- NVO's page on the SEC website